| Ytd | 15.61% | |
| 1y | 51.12% |
| Open | 237.79 | Prev Close | 238.96 | Low | 236.37 | High | 239.54 | Mkt Cap | 55.01B |
| Vol | 1.03M | Avg Vol | 1.89M | EPS | 7.23 | P/E | 32.86 | Forward P/E | 16.90 |
| Beta | 0.50 | Short Ratio | 4.49 | Inst. Own | 91.48% | Dividend | 2.06 | Div Yield | 0.86 |
| Ex Div Date | 10-01 | Earning | 11-05 | 50-d Avg | 233.04 | 200-d Avg | 218.73 | 1yr Est | 270.33 |
CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offse
Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous
Park National Corp OH trimmed its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 8.1% du
MassMutual Private Wealth and Trust FSB increased its stake in Cardinal Health, Inc. (NYSE: CAH) by
Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaff
Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to ex
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperfo
TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri
JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the pr
Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raise
Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperf
Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and rai
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raise
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price t
Cardinal Health posted mixed Q4 results, with adjusted earnings of $2.91 per share beating estimates
Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and rai
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the
CNN Fear & Greed Index: Market sentiment declined, but remained in Greed zone on Tuesday. Stocks
CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and appro
US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal
Cardinal Health recently completed an additional $350 million accelerated share repurchase program,
Stocks closed mostly lower on Monday, with the Fear and Greed index remaining in Greed zone. Investo
U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcoc
CAH to release Q4 earnings on Aug. 11, analysts expect EPS of $2.42 and revenue of $65.11B. Recently
Earnings set to hit the tape Tues. Options market implying post-print swings for 5 stocks, from heal
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises th
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raise
Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, i
Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory,
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price t
TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri
B of A Securities analyst Allen Lutz maintains Cardinal Health (NYSE:CAH) with a Buy and raises t
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b
JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and lowers the pr
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and lowers th
TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri
Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and low
A sharp rotation gripped Wall Street at midday Thursday as blue-chip industrials and healthcare powe
Cardinal Health (CAH) stock falls despite an EPS beat in Q3 2026. Revenue missed estimates at $60.9B
Cardinal Health (NYSE:CAH) raises FY2026 Adj EPS guidance from $10.15-$10.35 to $10.70-$10.80 vs $10
Cardinal Health (NYSE:CAH) reported quarterly earnings of $3.17 per share which beat the analyst con
Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperf
Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) prod